N
NextBioMedical Co Ltd
KOSDAQ:389650
NextBioMedical Co Ltd
KOSDAQ:389650
Price:
74 900
KRW
-3.6%
Market Closed
Market Cap:
₩614.2B
Balance Sheet
Balance Sheet Decomposition
NextBioMedical Co Ltd
NextBioMedical Co Ltd
Balance Sheet Decomposition is not available for
NextBioMedical Co Ltd
NextBioMedical Co Ltd
Balance Sheet
NextBioMedical Co Ltd
NextBioMedical Co Ltd
Currency: KRW
| Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|
| Assets | ||||
| Cash & Cash Equivalents |
3 014
|
3 902
|
4 950
|
|
| Cash |
0
|
0
|
0
|
|
| Cash Equivalents |
3 013
|
3 902
|
4 950
|
|
| Short-Term Investments |
11 783
|
10 388
|
36 658
|
|
| Total Receivables |
505
|
1 216
|
2 244
|
|
| Accounts Receivables |
389
|
1 026
|
2 088
|
|
| Other Receivables |
116
|
190
|
156
|
|
| Inventory |
1 940
|
2 169
|
2 581
|
|
| Other Current Assets |
279
|
293
|
454
|
|
| Total Current Assets |
17 521
|
17 968
|
46 888
|
|
| PP&E Net |
11 735
|
11 428
|
11 270
|
|
| PP&E Gross |
11 735
|
11 428
|
11 270
|
|
| Accumulated Depreciation |
1 171
|
1 511
|
1 777
|
|
| Intangible Assets |
222
|
218
|
344
|
|
| Note Receivable |
0
|
0
|
0
|
|
| Long-Term Investments |
2 637
|
0
|
0
|
|
| Other Long-Term Assets |
21
|
29
|
343
|
|
| Total Assets |
32 136
N/A
|
29 643
-8%
|
58 844
+99%
|
|
| Liabilities | ||||
| Accounts Payable |
45
|
58
|
13
|
|
| Accrued Liabilities |
107
|
121
|
126
|
|
| Short-Term Debt |
5 600
|
5 600
|
5 600
|
|
| Current Portion of Long-Term Debt |
24 763
|
27 292
|
4 565
|
|
| Other Current Liabilities |
453
|
714
|
1 579
|
|
| Total Current Liabilities |
30 968
|
33 786
|
11 884
|
|
| Long-Term Debt |
582
|
980
|
784
|
|
| Minority Interest |
0
|
0
|
0
|
|
| Other Liabilities |
840
|
778
|
985
|
|
| Total Liabilities |
32 390
N/A
|
35 544
+10%
|
13 653
-62%
|
|
| Equity | ||||
| Common Stock |
3 110
|
3 174
|
4 043
|
|
| Retained Earnings |
65 367
|
72 984
|
70 181
|
|
| Additional Paid In Capital |
60 679
|
61 632
|
107 234
|
|
| Other Equity |
1 324
|
2 277
|
4 095
|
|
| Total Equity |
254
N/A
|
5 901
-2 225%
|
45 191
N/A
|
|
| Total Liabilities & Equity |
32 136
N/A
|
29 643
-8%
|
58 844
+99%
|
|
| Shares Outstanding | ||||
| Common Shares Outstanding |
8
|
8
|
8
|
|
Switch to:
Switch to:
See Also
Discover More
